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ABSTRACT:  (Optimization of the cultivation conditions for the production of an antimicrobial compound by Trichosporon 
japonicum QU139.) Strain Trichosporon japonicum QU139 showed antimicrobial activity against several pathogenic fungi, and 
has good potential for being used in the development of a new antimicrobial agent. The objective of this work was to optimize 
the conditions for the production and detection of the antimicrobial compound produced by this strain. The antimicrobial effect 
was evaluated by the well method against sensitive cells of Cryptococcus gattii C20 in GYP and YM media at different pH va-
lues. GYP medium at pH 4.5 ± 0.5 and 24h of incubation, at 25ºC and 150 rpm, were defined as the best medium and cultivation 
conditions. The methodologies employed for the isolation and concentration of the antimicrobial compound were negative for 
antimicrobial activity, suggesting that it may not have a protein nature. The nature of the compound needs to be fully explored, 
and other methodologies, especially the ones for purification of glycolipids, must be employed in order to obtain a purified 
compound for biotechnological purposes.
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RESUMO: (Otimização das condições de cultivo para a produção de um composto antimicrobiano por Trichosporon japonicum 
QU139). A cepa Trichosporon japonicum QU139 mostrou atividade antimicrobiana contra vários fungos patogênicos, tendo um 
bom potencial para o desenvolvimento de um novo agente antimicrobiano. O objetivo do trabalho foi a otimização da produção 
e detecção do composto antimicrobiano. O efeito antimicrobiano foi avaliado pelo método de poços contra células sensíveis de 
Cryptococcus gattii C20 em meios GYP e YM em diferentes pH. O meio GYP, em pH 4.5 ± 0.5 e 24h de incubação a 25ºC e 150 
rpm, foram definidos como o melhor meio e condições de cultivo. As metodologias empregadas para isolamento e concentração 
do composto antimicrobiano foram negativas para atividade antimicrobiana, sugerindo que ele possa não ter natureza protéica. 
A natureza do composto precisa ser mais bem explorada e outras metodologias, especialmente as utilizadas em purificação de 
glicolipídeos, devem ser empregadas para obter um composto purificado visando aplicações biotecnológicas.
Palavras chave: Cryptococcus gattii, leveduras killer, potencial biotecnológico, Trichosporon japonicum.
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INTRODUCTION
The occurrence of fungal infections in the human 
population, caused by pathogenic fungi, has grown in 
recent times  (Ghannoum & Rice 1999, Lupetti et al. 
2002, Kanafani & Perfect 2008). The antifungal agents 
used to treat these infections belong to a few groups of 
drugs, and there are reports of resistance to many of these, 
while others are highly toxic to the patient (Lunardi et 
al. 2006, Severo et al. 2009). These facts emphasize the 
need for the development of new therapies. Cryptococcus 
neoformans and C. gattii cause an illness called crypto-
coccosis, which is one of the most common mycoses in 
immunodepressed patients. Cryptococcus gattii is usually 
associated to immunocompetent humans and animals, 
while C. neoformans affects immunocompromised pa-
tients (Severo et al. 2009). 
The production of antimicrobial compounds by yeasts 
is common and has been described in more than a hundred 
species and twenty genera.  These compounds belong to 
two main types: glycoproteins and glycolipids (Golubev 
2006). Glycoproteins, called mycocins or killer toxins, 
have been studied for over 40 years and a lot is known 
about the molecular characteristics of these toxins and 
their modes of action (Magliani et al. 1997, Schmitt & 
Breining 2002). Antibodies obtained from mycocins are 
being studied for the development of antifungal vacci-
nes (Polonelli et al. 1994, Magliani et al. 2004, Kabir 
et al. 2009, Krishnaswamy et al. 2010). The fungicidal 
activity of the extracellular glycolipids was discovered 
recently and is less known. Besides the clinical area, these 
antimicrobial compounds have applicability in the food 
industry, especially in fermentative processes, and in the 
biocontrol of plant and crustacean diseases (Santos & 
Marquina 2004, Comitini et al. 2004, Wang et al. 2007). 
In previous experiments performed in our laboratory, 
21 yeast strains were tested against several pathogenic 
fungi, including different species of Candida, C. neofor-
mans, C. gattii, dermatophytes, Sporothrix schenckii and 
Fonsecaea pedrosoi. Based on the results obtained, the 
yeast Trichosporon japonicum QU139 was chosen for 
the development of a new antifungal agent with a broad 
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spectrum of action. Fuentefria et al. (2008) showed that 
T. japonicum QU139 was capable of inhibiting all of the 
one hundred clinical and environmental isolates of C. 
gattii and C. neoformans tested. 
One of the major drawbacks for the industrial use 
of antimicrobial compounds produced by yeasts is the 
lack of accurate data on toxin production and activity 
(Barandica et al. 1999). In order to better characterize 
the production of the antimicrobial compound secreted 
by T. japonicum QU139, the objective of this work was 
to discover what the optimal cultivation conditions are 
for the production and detection of the antimicrobial 
compound produced by this strain, with the intention of 
purifying the compound in the future.
MATERIALS AND METHODS
Yeast strains
The strain T. japonicum QU139, isolated from artisanal 
cheese in the state of Rio Grande do Sul, Brazil (Landell 
et al. 2006) and deposited in the Yeast Culture Collec-
tion/UFRGS, was used as the mycocinogenic yeast. The 
sensitive strain Cryptococcus gattii C20 was a clinical 
isolate from a HIV positive patient, serotype B, molecular 
type VGIII, and mating type α.
Culture media
The cultures were maintained in GYP agar (2% glu-
cose; 1% peptone; 0.5% yeast extract; 2% agar) that was 
covered with sterile mineral oil, at 4°C. The medias for 
toxin production and detection were GYP broth and agar 
and YM broth and agar (1% glucose; 0.5% peptone; 0.3% 
yeast extract; 0.3% malt extract; 2% agar), which were 
both buffered with 0.05 M  citrate-phosphate buffer at 
different pH values (3.0 to 6.0). 
Production and detection of the antimicrobial 
compound
Approximately 10³ cells of T. japonicum QU139 were 
inoculated in 250 mL Erlenmeyer flasks containing 100 
mL of each medium, and then incubated for 48 hours. 
Modifications in the incubation temperature and agita-
tion were also tested: 25ºC or 30ºC, and 80 rpm or 150 
rpm, respectively. 30 µL of each culture supernatant, for 
each treatment, were inoculated in 9mm diameter wells 
on a Petri dish containing the respective media and pH, 
previously inoculated at the surface with 10³ sensitive 
cells of C. gattii C20. The activity of the antimicrobial 
compound was evaluated by measuring the diameter 
(mm) of the inhibition zone around the well after in-
cubation for 48h at 25°C. Data presented refer to the 
average of two independent experiments with less than 
10% standard deviation.
Monitoring of viable cells:
100 µL of each culture supernatant were inoculated 
in GYP agar and incubated for 48h at 25°C for quanti-
fication of viable cells. The number of generations and 
the specific growth rate were calculated according to the 
following formulae:
N= log Nt – log N0  
      log 2 
µ= N 
              T 
Where: 
N: number of generations
log Nt: log of cell number at the end of the log phase 
log N0: log of cell number at the beginning of the log 
phase
µ: specific growth rate 
T= duration of the log phase
All the numbers represent the average of two different 
experiments. 
Isolation and concentration of proteins / glyco-
proteins
The methodologies employed for the isolation and 
concentration of the antimicrobial compound, so it could 
be purified at a later date, were performed according 
to Scopes (1994), Santos & Marquina (2004), Buzzini 
et al. (2004) and Comitini et al. (2004). Trichosporon 
japonicum QU139 was grown in GYP pH 4.5 for 24 
hours at 25°C.
Precipitation with ammonium sulfate
100 mL of the culture supernatant were precipitated 
with ammonium sulfate in four saturation levels (0–20%; 
20–40%; 40–65% and 65–80%). The experiment was 
conducted under refrigeration (4°C) and agitation (80 
rpm). The salt quantity necessary for attaining each 
saturation level was calculated based on the volume of 
culture supernatant subjected to precipitation, according 
to Scopes (1994). After the addition of the corresponding 
quantity of salt, the suspension was maintained for 30 
minutes under agitation followed by 30 minutes under 
rest. The suspension was centrifuged (10,000xg for 
15 min) and the precipitate was suspended in 2 mL of 
citrate-phosphate buffer (0.05M, pH 4.5). The sample 
was dialyzed against the same buffer overnight. After 
this process, the activity in 30 µL was evaluated by the 
well method.
Precipitation with ethanol
1 L of the culture supernatant was centrifuged, filter-
-sterilized (0.45 µm), precipitated with 70% volume of 
cold ethanol, and kept at 4°C overnight. After centrifu-
gation (25 min at 3,000xg), the pellet was suspended 
in 50 mL of citrate-phosphate buffer (0.05 M, pH 4.5). 
Activity was evaluated by the well method. 
Ultrafiltration
 The protocol was adapted from Comitini et al. (2004). 
100 mL of the culture supernatant was filter-sterilized 
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(0.45 mm), concentrated to a final volume of 2 mL in an 
Amicon YM10 (10kD cut-off), kept at 4°C and evaluated 
by the well method.
Freeze-drying
The filter-sterilized culture supernatant was also 
subjected to freeze-drying for five days. The pellet was 
suspended in 50 mL of citrate-phosphate buffer, at pH 
4.5, and tested by the well method.
Co-culture
103 cells of C. gattii C20 in 10 mL of GYP broth were 
inactivated using an autoclave and added to 100 mL of T. 
japonicum QU139 in the same medium (pH 4.5, 150 rpm, 
for 24h) in order to know if the killer strain needed the 
contact with a sensitive cell to produce the antimicrobial 
compound. The supernatant of the co-culture was filter-
-sterilized and evaluated by the well method.
RESULTS
The size of the inhibition haloes produced by T. ja-
ponicum QU139 in GYP and YM at 25ºC and 80 rpm 
can be seen in Table 1. Both media showed the biggest 
haloes at 40–48 hours of incubation at pH 4.0 to pH 6.0. 
Incubation at 30ºC resulted in smaller inhibition haloes 
(data not shown). As the results were similar for both 
media, all other experiments were performed using GYP. 
An increase in agitation to 150 rpm resulted in the re-
duction of the incubation time required for the best toxin 
production (Table 2). The biggest haloes were produced 
at pH 4.0 to pH 5.0 in 24 hours. It is possible that higher 
rpm values would reduce the incubation time.
Growth curves were plotted along the experiments for 
comparison with the production of the antimicrobial com-
pound. The peak of production of the antimicrobial com-
pound coincided with the late exponential phase for all pH 
values tested (Tab. 2, Fig. 1). The specific growth rate and 
the duration of the lag and log phases of each growth curve 
are shown in Tab. 3. Although the lowest specific growth 
rate was obtained at pH 5.5, pH 4.0 to 5.0 were the best for 
antimicrobial compound production (Tab. 2). Therefore 
GYP medium at pH 4.5 ± 0.5 and incubation at 25ºC with 
150 rpm were defined as the best medium and cultivation 
conditions for production of the antimicrobial compound 
by strain T. japonicum QU139.
The methods for protein isolation were negative for anti-
microbial activity, while the controls, with the culture super-
natants containing cells, were always capable of producing 
inhibition haloes against the sensitive strain C. gattii C20 
(data not shown). Co-cultivation of T. japonicum QU139 
with dead cells of C. gattii C20 also did not produce inhibi-
tion haloes when the cell-free culture supernatant was tested.
DISCUSSION
Several factors may influence the activity of antimicro-
bial compounds produced by yeasts, such as pH, tempe-
rature and media composition. Usually, nutritionally rich 
media containing glucose, peptone and yeast extract and 
a low pH are used (Golubev 2006, Mimee et al. 2009). 
The peak of toxin production by T. japonicum QU139 
coincided with the end of the log phase, as observed 
for Kluyveromyces phaffii (Comitini et al. 2004). Toxin 
production lowered along the stationary phase. Barandica 
et al. (1999) proposed a mathematical model to explain 
toxin production by yeasts. According to these authors, 
Table 1. Halo diameters (mm) produced by the yeast T. japonicum 
QU139 in GYP and YM at 25ºC and 80 rpm.
 pH GYP  YM16h 24h 40h 48h 16h 24h 40h 48h
pH 3.0 0 0 17 17 15 22 0 0
pH 4.0 18 20 27 24 15 22 27 18
pH 5.0 20 21 25 27 16 22 26 20
pH 6.0 18 20 24 23  15 22 26 20
Table 2. Halo diameters (mm) produced by the yeast T. japonicum 
QU139 in GYP at 25ºC and 150 rpm.
pH Halo diameter (mm)24h 30h 36h 42h 48h
pH 4.0 29a 24a 25a 27a 24a
pH 4.5 32a 26a 26a 26a 26a
pH 5.0 32a 24a 22a 22a 23a
pH 5.5 24b 21a 21a 22a 19b
*Values followed by the same letter do not differ statistically by the 
Tukey Test (P = 0.05).
Table 3. Specific growth rate and duration of the lag and log phases 
for the strain T. japonicum QU139 in GYP medium at 25°C. 
pH μ (h-1) Duration of the phase (hours)lag log
pH 4.0  0,87 a* 12 12
pH 4.5 0,66 b 6 18
pH 5.0 0,64 b 6 18
pH 5.5 0,36 c 6 30
 CV (%) 1,18  
*Values followed by the same letter do not differ statistically by the 
















Figure 1. Growth curve of Trichosporon japonicum QU139 in GYP, 
at 150 rpm and 25°C, at pH 4.0 (ᴏ), 4.5 (□), 5.0 (∆ ), and 5.5 (×). 
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the process of toxin synthesis is simultaneous with its 
inactivation during the log phase, but synthesis does not 
take place along the stationary phase, resulting in lower 
toxin levels. 
The size of the inhibition haloes produced by T. ja-
ponicum QU139 were higher than the ones obtained 
by Fuentefria et al. (2008) for the same strain using C. 
gattii C20 as the sensitive yeast. This was probably due 
to the difference in the number of sensitive cells (106 
cells), pH (5.5), medium (YM) and incubation time (3–5 
days) applied by Fuentefria et al. (2008). These authors 
suggested the use of a panel of killer yeasts for biotyping 
C. neoformans / C. gattii in cell x cell experiments. The 
different halo sizes obtained in the present study points 
to the need of using the purified toxins in biotyping 
experiments instead of the intact cells as suggested by 
Buzzini et al. (2007). 
The methodologies used in this study for purification of 
the antimicrobial compound are the ones usually applied 
for the isolation/concentration of glycoproteins (Soares & 
Sato 2000, Santos & Marquina 2004). But the activity of 
T. japonicum QU139 against the sensitive cell was only 
evident when there was live cell-cell contact. It is possi-
ble that the compound was degraded and lost its activity 
during the aggressive conditions for precipitation or due 
to the presence of proteases. Alternatively, the agitation 
of the culture may have caused the inactivation of the 
antimicrobial compound, as reported for Saccharomyces 
cerevisiae and Kluyveromyces lactis (Kotani et al. 1977, 
Wilson & Whittaker 1989). In this case, the best results 
obtained in the present study for 150 rpm compared to 
80 rpm may be due to a better growth of T. japonicum 
QU139 under higher agitation and oxygenation. Finally, 
another explanation may be that the antimicrobial com-
pound does not have a protein nature.
The occurrences of protein and non-protein antimicro-
bial compounds in the genus Trichosporon have already 
been reported.  Trichosporon pullulans was reported to 
produce a protein toxin with the molecular weight of 
15kDa associated to the presence of dsRNA (Golubev 
et al. 2002). In previous studies, the strain T. japonicum 
QU139 presented dsRNA (Fuentefria 2007). More recen-
tly, Trichosporon porosum Pa20 was shown to produce 
a glycolipid (non-protein) compound active against as-
comycetous and basidiomycetous fungi (Kulakovskaya 
et al. 2009, 2010). The nature of the compound produced 
by T. japonicum QU139 needs to be fully explored, and 
other methodologies, especially the ones for purification 
of glycolipids, must be employed in order to obtain a 
purified compound for biotechnological purposes. 
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